GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 4026 - 4050 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgG Patient 1 10 moderate
G58547FH
22
IgG Patient 1 10 moderate
G76355TG
22
IgG Patient 1 10 moderate
G82779CI
22
IgG Patient 1 10 moderate
G98068PA
22
IgG Patient 1 22 moderate
G00051MO
22
IgG Patient 1 22 moderate
G00053MO
22
IgG Patient 1 22 moderate
G00054MO
22
IgG Patient 1 22 moderate
G00068MO
22
IgG Patient 1 22 moderate
G02557XE
22
IgG Patient 1 22 moderate
G47548GA
22
IgG Patient 1 22 moderate
G86566MF
22
IgG Patient 1 22 moderate
G94435QH
22
IgG Patient 1 6 moderate
G57449OF
22
IgG Patient 1 6 moderate
G58547FH
22
IgG Patient 1 6 moderate
G86566MF
22
IgG Patient 1 10 moderate
G24432YB
21
IgG Patient 1 10 moderate
G94435QH
21
IgG Patient 1 10 moderate
G96881BQ
21
IgG Patient 1 22 moderate
G24432YB
21
IgG Patient 1 22 moderate
G28868ZC
21
IgG Patient 1 22 moderate
G37383BH
21
IgG Patient 1 22 moderate
G82204SH
21
IgG Patient 1 6 moderate
G12200GB
21
IgG Patient 1 6 moderate
G37383BH
21
IgG Patient 1 10 moderate
G00068MO
19

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024